Stories of how inspired individuals or entire investigational teams worked to create a research company/site and overcome the challenges involved provide insights into their sustainability, and sometimes, success.
This column provides an overview of how institutional biosafety committees enhance and promote clinical research and scientific discovery.
This column explores the distinctions between registries and natural history studies, highlighting the potential value of each in informing and shaping clinical development in rare diseases.
This column highlights how incorporating data from patient disease registries in a real-world data mix offers four impactful benefits for clinical researchers.
Dispatches collected from sources in the world beyond ACRP (no endorsements implied) and edited for your reading pleasure on diversity, equity, and inclusion in healthcare and research.